Orgenesis Ltd.

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 50.0

EPO Patents = 5

Trademarks = 1

Forward Citations = 6

Loading Chart...

6 inventors (with patents filed for the assignee):

Sarah Ferber (6 out of 7 patents)

Luis Squiquera (2 out of 4 patents)

Jamie Sulley (2 out of 4 patents)

4. David Sidransky (1 out of 2 patents)

5. Tom Hodge (1 out of 1 patent)

6. Thomas W Hodge (1 out of 4 patents)

8 patents: Sort by Forward Citations

1. 11617769 - Methods of transdifferentiation and methods of use thereof (2023-04-04),

2. 11331378 - Prophylactic protection against viral infections (2022-05-17),

3. 10975354 - Transdifferentiated cell populations and methods of use thereof (2021-04-13),

4. 10947509 - Cell populations, methods of transdifferentiation and methods of use thereof (2021-03-16),

5. 10835598 - Prophylactic protection against viral infections, particularly HIV (2020-11-17),

6. 10668107 - Methods of transdifferentiation and methods of use thereof (2020-06-02),

7. 10179151 - Methods of transdifferentiation and methods of use thereof (2019-01-15),

8. 9982236 - Cell populations, methods of transdifferentiation and methods of use thereof (2018-05-29),

Company Overview

Orgenesis Ltd. is a global biotech company dedicated to the development of cutting-edge therapies in the field of cell and gene therapy. With a focus on innovative solutions for chronic diseases, Orgenesis is committed to improving patient outcomes and advancing the field of regenerative medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

8 Patents

#158 in Tel Aviv

#799 in Israel

Tel Aviv, Israel

Orgenesis Ltd.

Forward Citations = 6

6 inventors:

Sarah Ferber (6 out of 7 patents)

Luis Squiquera (2 out of 4 patents)

Jamie Sulley (2 out of 4 patents)

4. David Sidransky (1 out of 2 patents)

5. Tom Hodge (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orgenesis Ltd.. Retrieved from https://idiyas.com/company/orgenesis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]